1. Home
  2. CLMB vs CSTL Comparison

CLMB vs CSTL Comparison

Compare CLMB & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLMB
  • CSTL
  • Stock Information
  • Founded
  • CLMB 1982
  • CSTL 2007
  • Country
  • CLMB United States
  • CSTL United States
  • Employees
  • CLMB N/A
  • CSTL N/A
  • Industry
  • CLMB Retail: Computer Software & Peripheral Equipment
  • CSTL Medical Specialities
  • Sector
  • CLMB Technology
  • CSTL Health Care
  • Exchange
  • CLMB Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • CLMB 489.1M
  • CSTL 456.2M
  • IPO Year
  • CLMB N/A
  • CSTL 2019
  • Fundamental
  • Price
  • CLMB $107.50
  • CSTL $16.27
  • Analyst Decision
  • CLMB Buy
  • CSTL Strong Buy
  • Analyst Count
  • CLMB 1
  • CSTL 6
  • Target Price
  • CLMB $136.00
  • CSTL $37.67
  • AVG Volume (30 Days)
  • CLMB 70.8K
  • CSTL 488.5K
  • Earning Date
  • CLMB 04-30-2025
  • CSTL 05-05-2025
  • Dividend Yield
  • CLMB 0.63%
  • CSTL N/A
  • EPS Growth
  • CLMB 65.26
  • CSTL N/A
  • EPS
  • CLMB 4.26
  • CSTL N/A
  • Revenue
  • CLMB $511,229,000.00
  • CSTL $347,083,000.00
  • Revenue This Year
  • CLMB $19.60
  • CSTL N/A
  • Revenue Next Year
  • CLMB $8.00
  • CSTL $1.80
  • P/E Ratio
  • CLMB $25.39
  • CSTL N/A
  • Revenue Growth
  • CLMB 42.25
  • CSTL 38.43
  • 52 Week Low
  • CLMB $54.79
  • CSTL $15.45
  • 52 Week High
  • CLMB $145.00
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • CLMB 49.77
  • CSTL 38.96
  • Support Level
  • CLMB $104.01
  • CSTL $15.45
  • Resistance Level
  • CLMB $110.80
  • CSTL $16.43
  • Average True Range (ATR)
  • CLMB 3.71
  • CSTL 0.61
  • MACD
  • CLMB 0.27
  • CSTL 0.10
  • Stochastic Oscillator
  • CLMB 43.51
  • CSTL 43.85

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: